Verrica Pharmaceuticals Inc (VRCA) is down Thursday morning, with the stock decreasing -6.91% in pre-market trading to 2.02. VRCA's short-term technical score of 7 indicates that the stock has traded less bullishly over the last month than 93% of stocks on the market. In the Biotechnology industry, which ranks 118 out of 146 industries, the stock ranks higher than 10% of stocks. Verrica Pharmaceuticals Inc has risen 8.50% over the past month, closing at $1.95 on June 2. During this period of time, the stock fell as low as $1.95 and as high as $2.52. VRCA has an average analyst recommendation of Strong Buy. The company has an average price target of $13.83.
VRCA has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on VRCA!